Pathstone Family Office
ABMD

Pathstone Family Office’s Abiomed Inc ABMD Stock Holding History

Pathstone Family Office’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,930
Closed -$474K – 1441
2022
Q3 		$474K Buy
+1,930
New +$521K 0.01% 694
2021
Q1 		– Sell
-52
Closed -$17K – 1434
2020
Q4 		$17K Buy
+52
New +$14.4K ﹤0.01% 752
2019
Q2 		– Sell
-193
Closed -$54K – 950
2019
Q1 		$54K Buy
193
+5
+3% +$1.66K 0.01% 294
2018
Q4 		$61K Buy
+188
New +$65.3K 0.02% 168

Other funds holding ABMD

Teachers Retirement System of the State of Kentucky
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
Huntington National Bank
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Pathstone Family Office's ABMD Position: Q4 2022 in Review

Pathstone Family Office sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,930 shares — an estimated $474K sold.

Pathstone Family Office first reported a position in ABMD in Q4 2018 and held it in 4 quarters. The position peaked at $474K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Pathstone Family Office reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Pathstone Family Office sold 1,930 Abiomed Inc shares in Q4 2022, an estimated $474K.
  • Pathstone Family Office first reported a position in Abiomed Inc in Q4 2018 and held it in 4 quarters.
  • Pathstone Family Office's Abiomed Inc position peaked at $474K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.